| OCLVX | VVIAX | OCLVX / VVIAX | |
| Total Expense Ratio | 1.92 | 0.05 | 3,840% |
| Annual Report Gross Expense Ratio | 1.92 | 0.05 | 3,840% |
| Fund Existence | 23 years | 26 years | - |
| Gain YTD | 14.402 | 17.474 | 82% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.97B | 256B | 1% |
| Annual Yield % from dividends | 0.00 | 1.85 | - |
| Returns for 1 year | 15.40 | 26.98 | 57% |
| Returns for 3 years | 16.48 | 54.54 | 30% |
| Returns for 5 years | 7.36 | 60.56 | 12% |
| Returns for 10 years | 43.51 | 156.27 | 28% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TISEX | 24.29 | 0.34 | +1.42% |
| Nuveen Quant Small Cap Equity R6 | |||
| DHANX | 17.22 | 0.20 | +1.18% |
| Centre American Select Equity Investor | |||
| VPMAX | 232.29 | 1.47 | +0.64% |
| Vanguard PRIMECAP Adm | |||
| MENRX | 9.79 | 0.06 | +0.62% |
| Madison Covered Call & Equity Income R6 | |||
| BEMIX | 14.84 | 0.06 | +0.41% |
| Brandes Emerging Markets Value I | |||